Atostat

Leaflet accompanying the packaging: information for the user

Atostat, 10 mg, coated tablets

Atostat, 20 mg, coated tablets

Atostat, 40 mg, coated tablets

Atorvastatin

You should carefully read the contents of the leaflet before taking the medicine, as it contains important information for the patient.

• You should keep this leaflet, so that you can read it again if you need to.
• In case of any doubts, you should consult a doctor or pharmacist.
• This medicine has been prescribed to you specifically. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet:

• 1. What is Atostat and what is it used for
• 2. Important information before taking Atostat
• 3. How to take Atostat
• 4. Possible side effects
• 5. How to store Atostat
• 6. Contents of the packaging and other information

1. What is Atostat and what is it used for

Atostat belongs to a group of medicines called statins, which regulate lipid (fat) metabolism in the body.
Atostat is used to reduce the levels of lipids known as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes are not effective.
Atostat may also be used to reduce the risk of heart disease, even if cholesterol levels are normal. During treatment, a standard low-cholesterol diet should be continued.

2. Important information before taking Atostat

When not to take Atostat:

• in women of childbearing age who do not use effective methods of contraception,
• in pregnant or breastfeeding women,
• in women who are breastfeeding.

Warnings and precautions

Before taking Atostat, the patient should discuss it with their doctor, pharmacist, or nurse.

• in case of severe respiratory failure
• in case of a stroke with bleeding into the brain, or if there is a small amount of fluid in the brain from a previous stroke,
• in case of kidney problems,
• in case of hypothyroidism,
• in case of recurring or unexplained muscle pain or muscle problems in the past or similar problems in relatives,
• in case of muscle problems during previous treatment with other lipid-lowering medicines (e.g., other statins or fibrates),
• in case of regular consumption of large amounts of alcohol,
• in case of liver disease in the past,
• in patients over 70 years of age.

In patients who are affected by any of the above situations, the doctor will order a blood test before starting treatment with Atostat and, if possible, during treatment to monitor the risk of side effects related to the muscles. It is known that the risk of side effects related to the muscles, such as rhabdomyolysis, is greater when certain medicines are taken concurrently (see section 2 "Other medicines and Atostat").
The patient should also inform their doctor or pharmacist if they suffer from persistent muscle weakness. Additional tests and medicines may be needed to diagnose and treat muscle weakness.
During treatment with this medicine, the patient's health will be closely monitored if they have diabetes or are at risk of developing diabetes. The patient is at risk of developing diabetes if they have high levels of sugars and fats in the blood, are overweight, and have high blood pressure.

Other medicines and Atostat

The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
If the patient needs to take fusidic acid orally for the treatment of a bacterial infection, it will be necessary to temporarily stop taking Atostat. The doctor will inform them when it is possible to safely resume treatment with Atostat.
Taking Atostat with fusidic acid can rarely lead to muscle weakness, tenderness, or pain (rhabdomyolysis). More information on rhabdomyolysis can be found in section 4.
Some medicines may change the effect of Atostat or the effect of these medicines on the body may be changed by Atostat. This type of interaction can lead to reduced efficacy of one or both medicines. At the same time, it can increase the risk of serious side effects, including severe muscle damage known as rhabdomyolysis, described in section 4:

• medicines that modify the immune system, such as cyclosporine,
• certain antibiotics and antifungal medicines, such as erythromycin, clarithromycin, telithromycin, ketoconazole, itraconazole, voriconazole, fluconazole, posaconazole, rifampicin, fusidic acid,
• other medicines that regulate lipid levels, such as gemfibrozil, other fibrates, cholestyramine,
• certain calcium channel blockers used for angina or high blood pressure, such as amlodipine, diltiazem, as well as medicines that regulate heart rhythm, such as digoxin, verapamil, amiodarone,
• medicines used to treat HIV infection, such as ritonavir, lopinavir, atazanavir, indinavir, darunavir, tipranavir in combination with ritonavir, etc.,
• certain medicines used to treat hepatitis C, such as telaprevir,
• other medicines that are known to interact with Atostat, such as ezetimibe (which lowers cholesterol), warfarin (which reduces blood clotting), oral contraceptives, stiripentol (an antiepileptic medicine used to treat epilepsy), cimetidine (used to treat heartburn and stomach ulcers), phenazone (a pain reliever), colchicine (used to treat gout), antacids (medicines used for indigestion, containing aluminum or magnesium), and boceprevir (used to treat liver diseases such as hepatitis C),
• over-the-counter medicines: St. John's wort.

Taking Atostat with food and drink

Information on taking Atostat can be found in section 3. However, attention should be paid to the following information:
Grapefruit juice
Do not drink more than one or two small glasses of grapefruit juice per day, as larger amounts of grapefruit juice may change the effect of Atostat.
Alcohol
While taking Atostat, the patient should avoid consuming excessive amounts of alcohol. More information on this can be found in section 2 "Warnings and precautions".

Pregnancy and breastfeeding

Taking Atostat during pregnancy or breastfeeding is contraindicated.
Taking Atostat in women of childbearing age is contraindicated if they do not use effective methods of contraception.
Taking Atostat during breastfeeding is contraindicated.
The safety of taking Atostat during pregnancy and breastfeeding has not been established.
Before taking any medicine, the patient should consult their doctor or pharmacist.

Driving and using machines

Normally, the medicine does not affect the ability to drive or use machines. However, the patient should not drive if the medicine affects their ability to drive.
The patient should not use any tools or machines if taking the medicine affects their ability to use them.

Atostat contains lactose

Patients who have been informed by their doctor about intolerance to certain sugars should contact their doctor before taking Atostat.

3. How to take Atostat

Atostat should always be taken as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist again.
Before starting treatment, the doctor will recommend a low-cholesterol diet; this diet should be continued during treatment with Atostat.
The recommended initial dose of Atostat for adults and children over 10 years of age is 10 mg once a day. This dose may be increased by the doctor if necessary to a dose suitable for the patient. The doctor will adjust the dose of Atostat at intervals of 4 weeks or more. The maximum dose of Atostat is 80 mg once a day for adults and 20 mg once a day for children.
Atostat tablets should be swallowed whole, with a glass of water; they can be taken at any time of day, with or without food. However, the patient should try to take the tablet at the same time every day.

The duration of treatment with Atostat is determined by the doctor.

If the patient feels that the effect of Atostat is too strong or too weak, they should consult their doctor.

Taking a higher dose of Atostat than recommended

In case of accidental ingestion of too many Atostat tablets (more than the usual daily dose), the patient should contact their doctor or the nearest hospital for advice.

Missing a dose of Atostat

If the patient forgets to take a dose, they should simply take the next dose at the scheduled time. They should not take a double dose to make up for the missed dose.

Stopping treatment with Atostat

In case of doubts about taking the medicine, the patient should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, Atostat can cause side effects, although not everybody gets them.

If the patient experiences any of the serious side effects, they should stop taking the medicine and contact their doctor or go to the emergency department of the nearest hospital immediately.

Raremay occur in up to 1 in 1000 people

• Severe allergic reaction causing swelling of the face, tongue, and throat, which can cause severe breathing difficulties.
• Severe disease characterized by peeling and swelling of the skin, blisters on the skin, mouth, eyes, genitals, and fever. Rash with pink-red spots, especially on the palms or soles, with possible blisters.
• Muscle weakness, tenderness, or pain. If the patient also experiences malaise or high fever, it may be caused by abnormal muscle breakdown. Abnormal muscle breakdown does not always go away, even after stopping atorvastatin, and can be life-threatening and cause kidney problems.

Very raremay occur in up to 1 in 10,000 people

• If the patient experiences unexpected or unusual bleeding or bruising, it may indicate liver problems. They should consult their doctor as soon as possible.

Other possible side effects of Atostat:

Common(may occur in up to 1 in 10 people)

• nasal congestion, sore throat, nosebleeds,
• allergic reactions,
• increased blood glucose levels (in patients with diabetes, blood glucose levels should continue to be closely monitored), increased blood creatine kinase levels,
• headaches,
• nausea, constipation, bloating, indigestion, diarrhea,
• joint pain, muscle pain, and back pain,
• blood test results indicating abnormal liver function.

Uncommon(may occur in up to 1 in 100 people)

• loss of appetite, weight gain, decreased blood glucose levels (in patients with diabetes, blood glucose levels should continue to be closely monitored),
• nightmares, insomnia,
• dizziness, numbness or tingling of fingers and toes, decreased sensitivity to pain and touch, changes in taste, memory loss,
• blurred vision,
• ringing in the ears or head,
• vomiting, belching, upper and lower abdominal pain, pancreatitis (causing abdominal pain),
• hepatitis,
• rash, skin rash, and itching, hives, hair loss,
• neck pain, muscle fatigue,
• fatigue, malaise, weakness, chest pain, swelling, especially of the ankles, elevated temperature,
• presence of white blood cells in the urine.

Rare(may occur in up to 1 in 1000 people)

• vision disorders,
• unexpected bleeding or bruising (bruises),
• cholestasis (yellowing of the skin and whites of the eyes),
• tendon rupture.

Very rare(may occur in up to 1 in 10,000 people)

• allergic reactions - symptoms may include sudden wheezing and chest pain or tightness, swelling of the eyelids, face, lips, mouth, tongue, or throat, difficulty breathing, collapse,
• hearing loss,
• gynecomastia (excessive growth of breast tissue in men).

Side effects of unknown frequency: persistent muscle weakness.

The following side effects have been reported with other statins:

Possible side effects reported during treatment with some statins (medicines of the same type):

• sexual disorders,
• depression,
• breathing problems, including persistent cough and (or) shortness of breath or fever,
• diabetes; the onset of diabetes is more likely if the patient has high levels of sugars and fats in the blood, is overweight, and has high blood pressure. The doctor will monitor the patient's condition while taking this medicine.

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, e-mail: [email protected]
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.

5. How to store Atostat

Store in a place out of sight and reach of children.
Do not take Atostat after the expiry date stated on the carton and blister after "EXP". The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer need. This will help protect the environment.

6. Contents of the packaging and other information

What Atostat contains

• The active substance of Atostat is atorvastatin. Each coated tablet contains 10 mg of atorvastatin (in the form of atorvastatin calcium). Each coated tablet contains 20 mg of atorvastatin (in the form of atorvastatin calcium). Each coated tablet contains 40 mg of atorvastatin (in the form of atorvastatin calcium). Each coated tablet contains 80 mg of atorvastatin (in the form of atorvastatin calcium).
• The other ingredients of Atostat are:
  Core: mannitol, sodium lauryl sulfate, colloidal silicon dioxide, sodium carbonate, butylhydroxyanisole, microcrystalline cellulose, sodium croscarmellose, magnesium stearate.
  Coating: hypromellose 15cP, microcrystalline cellulose, stearic acid.

What Atostat looks like and what the pack contains

10 mg coated tablets
white, oval, biconvex tablets with the marking "10" on one side and smooth on the other.
20 mg coated tablets
white, oval, biconvex tablets with the marking "20" on one side and smooth on the other.
40 mg coated tablets
white, oval, biconvex tablets with the marking "40" on one side and smooth on the other.
Atostat is packaged in a aluminum blister sealed with a heat-sealable aluminum foil.
The pack contains 30 coated tablets in a cardboard box.

Marketing authorization holder:

Artespharm Sp. z o.o.
Solec 81 B, lok. A-51,
00-382 Warsaw, Poland

Name and address of the importer who releases the series:

Mako Pharma Sp z o.o.
Wiśniowa 9, 05-092 Kiełpin

Date of the last update of the leaflet: